Skip to main content

Table 5 Cumulative duration of statin use in cases and controls in 13 to 120 months prior to the index date by cancer site in cases and controls with 10 or more years of recorded data

From: Exposure to statins and risk of common cancers: a series of nested case-control studies

 

Less than 12 months

13 to 24 months

25 to 48 months

49 to 72 months

73 months and more

 

cancer

Cases/Controls

Adjusted Odds ratio (95%CI) #

Cases/Controls

Adjusted Odds ratio (95%CI) #

Cases/Controls

Adjusted Odds ratio (95%CI) #

Cases/Controls

Adjusted Odds ratio (95%CI) #

Cases/Controls

Adjusted Odds ratio (95%CI)#

P-* value

breast†

363/1338

1 (0.86 to 1.16)

254/962

0.96 (0.81 to 1.15)

346/1208

1.06 (0.90 to 1.25)

169/634

0.93 (0.75 to 1.15)

131/542

0.85 (0.67 to 1.08)

0.220

prostate

545/2119

0.99 (0.87 to 1.12)

489/1609

1.19 (1.04 to 1.36)

641/2424

1.06 (0.94 to 1.19)

369/1394

1.07 (0.93 to 1.24)

320/1234

1.12 (0.96 to 1.32)

0.173

colorectal‡

446/1527

1.06 (0.92 to 1.23)

327/1224

1.03 (0.88 to 1.21)

429/1625

0.97 (0.84 to 1.13)

285/902

1.20 (1.01 to 1.43)

213/711

1.21 (0.99 to 1.48)

0.069

lung

419/1375

1.06 (0.91 to 1.25)

342/1064

1.21 (1.01 to 1.43)

458/1586

1.05 (0.89 to 1.23)

259/950

1.00 (0.82 to 1.21)

235/734

1.17 (0.95 to 1.45)

0.240

blood

202/821

0.72 (0.59 to 0.88)

160/616

0.8 (0.64 to 1.00)

233/966

0.74 (0.61 to 0.89)

133/468

0.87 (0.68 to 1.11)

90/428

0.55 (0.41 to 0.73)

< 0.001

bladder

172/565

1.14 (0.91 to 1.43)

137/456

1.19 (0.93 to 1.53)

190/681

1.01 (0.81 to 1.26)

117/360

1.19 (0.91 to 1.57)

94/280

1.37 (1.02 to 1.86)

0.062

skin

110/312

1.41 (1.04 to 1.89)

56/270

0.79 (0.55 to 1.13)

112/349

1.21 (0.89 to 1.64)

50/176

0.87 (0.56 to 1.36)

56/185

1.04 (0.70 to 1.55)

0.626

oesophagus

103/409

0.9 (0.67 to 1.20)

75/272

1.01 (0.72 to 1.42)

105/445

0.81 (0.61 to 1.09)

68/248

1.09 (0.77 to 1.55)

59/185

1.03 (0.70 to 1.52)

0.870

pancreas

76/277

0.89 (0.63 to 1.24)

61/196

1.22 (0.84 to 1.78)

86/286

0.99 (0.71 to 1.38)

50/172

1.04 (0.69 to 1.56)

40/148

0.85 (0.53 to 1.37)

0.475

stomach

58/232

0.84 (0.58 to 1.22)

60/206

0.82 (0.56 to 1.19)

77/301

0.86 (0.61 to 1.21)

35/150

0.56 (0.35 to 0.90)

38/165

0.63 (0.39 to 1.00)

0.008

All cancers

2890/10413

0.99 (0.94 to 1.05)

2303/8005

1.05 (0.99 to 1.11)

3107/11437

0.98 (0.93 to 1.03)

1776/6319

1.01 (0.95 to 1.08)

1462/5259

1.02 (0.95 to 1.10)

0.958

  1. # Adjusted for Townsend quintile, body mass index, smoking status, myocardial infarction, coronary heart disease, diabetes, hypertension, stroke, rheumatoid arthritis, use of NSAIDs, Cox2-inhibitors, aspirin
  2. † Also adjusted for family history of breast cancer, benign breast disease, use of oral contraceptives, hormone-replace therapy
  3. ‡ Also adjusted for colitis and Crohn's disease
  4. * Trend test based on number of months prescribed